BDX
BDXXNYS

Becton, Dickinson and Co.

Market cap $43.1B

$156.36

-26.58 (-14.53%)past year

BDX

$156.36

+2.22% today

Market price$156.36
Shares1
Est. total$156.36

Buy with €1M virtual cash · No real money

Becton, Dickinson and Co. (BDX) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates BDX a Sell, with the stock down 14% over the past year. You can practice trading BDX risk-free with €1,000,000 in virtual cash.

Key stats

As of July 27, 2026

Market Cap

$43.1B

Volume

1.1M

52-wk High

$213.08

52-wk Low

$140.11

Day High

$156.80

Day Low

$153.32

P/E (TTM)

39.58

Revenue (TTM)

$21.4B

EPS (TTM)

$3.95

Performance

1M

+5.8%

6M

-24.1%

1Y

-14.4%

Invest signal · BDX

Sell
SellHoldBuy
1-year trend-14%
3-month momentum+1%
Valuation (P/E)39.6
Revenue growth (QoQ)-10.2%
Profitability (EPS)Unprofitable

Algorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.

BDX overview

AI overview

Revenue & EPS — last 8 quarters

QoQ rev -10.2%

Revenue

$5B
Q2 '24
Q3 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26

EPS (diluted)

$-1.11 per share
Q2 '24
Q3 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26

About Becton, Dickinson and Co.

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms.

Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Employees

72,000

www.bd.com

30-Day Win Rate · BDX

57%WIN RATE
Up days

13 days

Down days

10 days

Last 23 sessions

How to practice trading BDX

  1. 1

    Use the BDX buy panel above

    Set a quantity and hit Buy at the real market price — right here, nothing to download.

  2. 2

    Trade with €1,000,000 virtual cash

    You get a million in virtual money instantly to invest, risk-free.

  3. 3

    Create a free account to save it

    Sign up in seconds to keep your portfolio and track its performance.

  4. 4

    Track and compete

    Watch your portfolio grow and climb the global leaderboard — or start a private league.

  5. 5

    Prefer mobile? Get the iOS app

    Invest is also free on the App Store, synced with your web account.

Top BDX traders on Invest

Full leaderboard
🥇Hannah S.+131.0%
🥈Julia M.+121.0%
🥉lena.h+114.0%
#4sophie.l+111.0%
#5Ben Carter+106.0%

Frequently asked questions

Is BDX a good stock to buy right now?

As of July 27, 2026, Invest's signal rates BDX a Sell, based on its price trend, valuation, and fundamentals (P/E around 39.6), with the stock down 14% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading BDX risk-free first.

What is Becton, Dickinson and Co.'s (BDX) market cap?

Becton, Dickinson and Co. has a market capitalization of approximately $43.1B, on trailing-twelve-month revenue of about $21.4B.

How has BDX stock performed?

BDX is down 14% over the past year and down 24% over six months. Its 52-week range runs roughly from $140.11 to $213.08. Past performance doesn't predict future results.

How can I practice trading BDX for free?

On Invest you get €1,000,000 in virtual cash and can buy BDX at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.

More stocks to practice

Compare BDX with peers

Invest — Stock Market SimulatorNot financial advice.